The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs

por Schreiber, André, Ambrosy, Benjamin, Planz, Oliver, Schloer, Sebastian, Rescher, Ursula, Ludwig, Stephan
Publicado 2022

Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms

por Walbaum, Stefan, Ambrosy, Benjamin, Schütz, Paula, Bachg, Anne C., Horsthemke, Markus, Leusen, Jeanette H.W., Mócsai, Attila, Hanley, Peter J.
Publicado 2021